Fig. 2From: Deregulation of IL-37 and its miRNAs modulators in sarcopenic patients after rehabilitationInterleukin-(IL)-18 (a) and Interleukin-(IL)-37 (b) plasma concentration at baseline (T0) and at the end of the 30Â days rehabilitation protocol (T1). Median CRP concentration (mg/dL) and statistical significance (paired sample t-test) are shownBack to article page